Femasys Inc.
General ticker "FEMY" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $21.7M (TTM average)
Femasys Inc. does not follow the US Stock Market performance with the rate: -20.5%.
Estimated limits based on current volatility of 4.4%: low 0.36$, high 0.39$
Factors to consider:
- Total employees count: 27 as of 2021
- US accounted for 94.6% of revenue in the fiscal year ended 2023-12-31
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.37$, 1.12$]
- 2026-12-31 to 2027-12-31 estimated range: [0.40$, 1.16$]
Financial Metrics affecting the FEMY estimates:
- Positive: with PPE of -1.4 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: -9.55 < Industry operating profit margin (median), % of -3.62
- Positive: 19.24 < Shareholder equity ratio, % of 28.32 <= 42.59
- Positive: -0.03 < Industry operating cash flow per share per price (median), % of 1.51
Short-term FEMY quotes
Long-term FEMY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1.07MM | $1.63MM | $2.29MM |
| Operating Expenses | $15.58MM | $19.41MM | $19.88MM |
| Operating Income | $-14.51MM | $-17.79MM | $-17.59MM |
| Non-Operating Income | $0.27MM | $-1.02MM | $-1.04MM |
| Interest Expense | $0.17MM | $1.60MM | $1.89MM |
| R&D Expense | $7.21MM | $8.22MM | $7.58MM |
| Income(Loss) | $-14.24MM | $-18.81MM | $-18.63MM |
| Taxes | $0.00MM | $0.01MM | $0.00MM |
| Net Income(Loss)* | $-14.25MM | $-18.82MM | $-18.63MM |
| Stockholders Equity | $18.35MM | $2.30MM | $5.87MM |
| Inventory | $0.67MM | $3.05MM | $5.74MM |
| Assets | $27.76MM | $12.45MM | $20.72MM |
| Operating Cash Flow | $-11.28MM | $-19.44MM | $-18.69MM |
| Capital expenditure | $0.14MM | $0.76MM | $0.53MM |
| Investing Cash Flow | $-0.14MM | $-0.85MM | $-0.63MM |
| Financing Cash Flow | $20.18MM | $2.03MM | $25.14MM |
| Earnings Per Share** | $-0.93 | $-0.85 | $-0.47 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.